Kelly Lauren Guy, MD
Internal Medicine · Bend
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 15 years
- Stanford University School of Medicine, 2011
Offices
3 locations · Mosaic Community Health · 78 clinicians in this group
Hospitals listed: St Charles Bend Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Guy’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A157099 · Delinquent
Licence status: Delinquent · since 2018 · expires 2024-07-31 · Stanford University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Charles Medical Center - BendBend, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Charles Health System, which runs 4 hospitalsPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.257, Oct 2024 – Sep 2025
See every measure and the patient survey for St Charles Medical Center - Bend
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.257 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.27 to 1.9) · 2,321 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.73 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.8 (125.24 to 216.36) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 333 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 631 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 582 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 440 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 5,184 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.1 to 0.45) · 9,942 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.38) · 10,084 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.95 (2.38 to 5.51) · 3,553 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.99 (0.7 to 3.28) · 1,698 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.38 (1.18 to 3.57) · 3,393 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.13 (2.82 to 11.45) · 1,643 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.37 (0.57 to 6.16) · 1,621 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.19 (0.84 to 3.54) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.83 (0.32 to 1.33) · 7,772 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 162 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.959 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.533 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.458 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.29 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.138 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 437 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 860 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3.9 · 346 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -34.5 · 685 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.9 · 597 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 766 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (4 to 7.2) · 459 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.5 (7.4 to 12.1) · 459 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 157 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (9.2 to 14.6) · 2,646 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 1,198 cases | No different | Jan 2024 – Dec 2024 |
What patients said (892 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$318
Medicare paid this office $318 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of needle into vein for collection of blood sample | 14 | $130 | $9 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 75 · Health risk score 1.13. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 68%.
The office billed $531, Medicare allowed $324 and paid $318; for 34 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 34 | 75 | 1.13 | $531 | $318 |
| 2022 | 258 | 664 | 78 | 2.43 | $279,996 | $66,719 |
| 2021 | 306 | 628 | 77 | 2.26 | $283,148 | $69,032 |
| 2020 | 100 | 217 | 78 | 2.22 | $93,800 | $24,044 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 147 | $37,235 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,228 | $175 |
| Hospital discharge day management, more than 30 minutes | 93 | $9,214 | $95 |
| Initial hospital observation care per day, typically 70 minutes | 26 | $4,056 | $156 |
| Hospital observation care on day of discharge | 19 | $1,047 | $55 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 137 | $28,447 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $15,373 | $177 |
| Hospital discharge day management, more than 30 minutes | 96 | $9,565 | $97 |
| Initial hospital observation care per day, typically 70 minutes | 37 | $6,446 | $165 |
| Hospital observation care on day of discharge | 32 | $2,214 | $67 |
| Follow-up observation care per day, typically 35 minutes | 16 | $1,893 | $95 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $11,521 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,187 | $185 |
| Hospital discharge day management, more than 30 minutes | 30 | $3,051 | $98 |
| Hospital observation care on day of discharge | 12 | $921 | $77 |
Medicaid work
$3,251 in 2024
Medicaid paid $3,251 for 423 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 111 | $1,473 |
| Return visit (30+ min) | 127 | $1,295 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $156 |
| New patient visit (30+ min) | 12 | $94 |
| Blood test, lipids (cholesterol and triglycerides) | 31 | $86 |
| COMPREHENSIVE METABOLIC PANEL | 44 | $59 |
| Hemoglobin A1C level | 25 | $39 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 34 | $37 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 27 | $12 |
| 2024 | 423 | 9 | 22 | $3,251 |
| 2023 | 158 | 5 | 20 | $998 |
| 2022 | 31 | 2 | 12 | $1,069 |
| 2021 | 45 | 1 | 13 | $1,040 |
| 2020 | 24 | 1 | 14 | $733 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 76 | $508 |
| Return visit (30+ min) | 43 | $405 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $46 |
| COMPREHENSIVE METABOLIC PANEL | 12 | $27 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $12 |
2022
| 1ST HOSP IP/OBS HIGH 75 | 12 | $555 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 19 | $514 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 45 | $1,040 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $733 |
Drugs they prescribed that Part D paid
$170,471
Pharmacies billed $170,471 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (75 of 1,698) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,393 generic and 292 brand-name prescriptions · $170,471 in drug cost · 26 antibiotic prescriptions to 15 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 33 | $23,106 | $700 |
| Trelegy Ellipta | 24 | $18,917 | $788 |
| Ozempic | 11 | $13,315 | $1,210 |
| Trulicity | 14 | $12,952 | $925 |
| Shingrix | 12 | $2,217 | $185 |
See all 43 drugs
| Eliquis | 33 | $23,106 | $700 |
| Trelegy Ellipta | 24 | $18,917 | $788 |
| Ozempic | 11 | $13,315 | $1,210 |
| Trulicity | 14 | $12,952 | $925 |
| Shingrix | 12 | $2,217 | $185 |
| Pregabalin | 27 | $1,479 | $55 |
| Albuterol Sulfate Hfa | 36 | $1,250 | $35 |
| Atorvastatin | 94 | $1,207 | $13 |
| Gabapentin | 73 | $988 | $14 |
| Lantus Solostar | 14 | $839 | $60 |
| Clobetasol Propionate | 14 | $653 | $47 |
| Losartan | 63 | $642 | $10 |
| Levothyroxine | 64 | $538 | $8 |
| Duloxetine | 21 | $474 | $23 |
| Omeprazole | 31 | $469 | $15 |
| Amlodipine Besylate | 43 | $455 | $11 |
| Metoprolol | 26 | $423 | $16 |
| Dicyclomine | 11 | $413 | $38 |
| Hydrocodone-Acetaminophen | 30 | $380 | $13 |
| Trazodone | 43 | $376 | $9 |
| Pantoprazole | 30 | $343 | $11 |
| Tamsulosin | 16 | $321 | $20 |
| Montelukast | 11 | $307 | $28 |
| Fluticasone Propionate | 15 | $306 | $20 |
| Metoprolol | 22 | $279 | $13 |
| Sertraline | 27 | $255 | $9 |
| Naproxen | 25 | $247 | $10 |
| Cyclobenzaprine | 24 | $244 | $10 |
| Lisinopril | 29 | $225 | $8 |
| Bupropion Xl | 11 | $218 | $20 |
| Mirtazapine | 17 | $212 | $12 |
| Escitalopram | 23 | $193 | $8 |
| Finasteride | 11 | $186 | $17 |
| Tramadol | 20 | $176 | $9 |
| Furosemide | 42 | $172 | $4 |
| Metformin | 17 | $169 | $10 |
| Oxycodone | 13 | $167 | $13 |
| Alendronate | 14 | $151 | $11 |
| Tizanidine | 12 | $140 | $12 |
| Potassium Chloride | 11 | $140 | $13 |
| Meloxicam | 16 | $128 | $8 |
| Ondansetron Odt | 13 | $109 | $8 |
| Fluoxetine | 17 | $103 | $6 |
Year by year
| 2024 | 1,698 | 215 | 4% (75) | 17% | $170,471 |
| 2023 | 273 | 80 | None | None | $18,188 |
| 2022 | 159 | 66 | 11% (17) | None | $23,379 |
| 2021 | 179 | 71 | 7% (13) | None | $20,029 |
| 2020 | 55 | 28 | None | None | $5,971 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gabapentin | 17 | $144 | $8 |
2021: 1 drug
| Furosemide | 16 | $42 | $3 |
Money from drug and device companies
$31 in 2023
A payment is not proof that care is biased.
| Abbvie | Liletta | $31 | 1 payment
|
See the published payment
| Abbvie | Meals · 2023-10-30 | Liletta | $31 |
Professional record
- NPI
- 1861927485
- Licence
- CA A157099, OR MD213731California A157099: Delinquent · expires 2024-07-31
- Trained
- Stanford University School of Medicine, 2011 · 15 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 600 Sw Columbia St Ste 6250, Bend, OR, 97702
- NPI first listed
- 2017-04-21
- NPI last updated
- 2024-02-15
- NPI record certified
- 2024-02-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305